Leading the Way in Life Science Technologies

GEN Exclusives

More »
Readers Comments Back to Item »

BAC Targeting Biosimilar Market

1 Readers' Comments

Posted by: Lester Savit

12/11/2011

In October a federal court blocked market entry of a generic version of a complex active ingredient because of a patent on manufacturing (quality) control.  See www.lestersavit.com for a discussion of how this ruling reveals a new patent strategy for biosimilars.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »